No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full […]

News

Fresh Start Surgical Gifts Hosts 32nd Annual Celebrity Golf Classic Hosted by Alfonso Ribeiro, Transforming Lives One Swing at a Time

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Nationally recognized nonprofit, Fresh Start Surgical Gifts is teeing up for its 32nd Annual San Diego Celebrity Golf Classic, celebrating another year of transforming lives. The event will […]

News

Avidity Biosciences Honors Rare Disease Day®

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its support for Rare […]

News

Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

SAN DIEGO–(BUSINESS WIRE)–Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

News

‘Gene of Prejudice’ Demystifies Autism

Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego […]

News

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

SAN DIEGO, Feb. 28, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, March 12, 2024, at […]

News

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2023. “2023 was a transformational year for Acadia that positioned us for continued […]

News

With a Two-Year Revenue Growth of 530%, Cymbiotika Ranks No. 31 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies

Companies on the 2024 Inc. 5000 Regionals: Pacific list had an average growth rate of 162.77 percent. SAN DIEGO, Feb. 27, 2024 /PRNewswire/ — Inc. magazine today revealed that Cymbiotika, a leading lifestyle and wellness […]

No Picture
News

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) — – Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company […]

No Picture
News

VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium

BRIDGEWATER, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced […]

No Picture
Drug Development

STAT+: Obesity drug from Viking Therapeutics hits target in Phase 2 study, raising hopes for a competitor to existing medicines

An obesity drug from Viking Therapeutics succeeded in a Phase 2 study, helping patients lose nearly 15% of weight and further fueling the competition in the obesity market.  Click here to view original post Click […]